User profiles for Carl M.J. Kirkpatrick

Carl Kirkpatrick

Monash University
Verified email at monash.edu
Cited by 11376

Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis

JF Roos, J Doust, SE Tett, CMJ Kirkpatrick - Clinical biochemistry, 2007 - Elsevier
OBJECTIVES:: To perform a systematic review comparing the diagnostic accuracy of CysC
with SCr. METHODS:: MEDLINE and EMBASE (January 1984–February 2006) were …

Resveratrol–pills to replace a healthy diet?

VS Chachay, CMJ Kirkpatrick… - British journal of …, 2011 - Wiley Online Library
Nutrapharmacology, or the use of bioactive food compounds at pharmacological doses is
emerging as a therapeutic approach to target the complex metabolic dysregulations in ageing …

The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007

SC McLeay, GA Morrish, CMJ Kirkpatrick… - Clinical …, 2012 - Springer
Background: A variety of body size covariates have been used in population pharmacokinetic
analyses to describe variability in drug clearance (CL), such as total body weight (TBW), …

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing …

JA Roberts, CMJ Kirkpatrick, MS Roberts… - Journal of …, 2009 - academic.oup.com
Objectives To compare the plasma and subcutaneous tissue concentration–time profiles of
meropenem administered by intermittent bolus dosing or continuous infusion to critically ill …

Resveratrol does not benefit patients with nonalcoholic fatty liver disease

…, GP Thomas, GJ Cowin, CMJ Kirkpatrick… - Clinical …, 2014 - Elsevier
Background & Aims Nonalcoholic fatty liver disease (NAFLD), characterized by accumulation
of hepatic triglycerides (steatosis), is associated with abdominal obesity, insulin resistance, …

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

JA Roberts, CMJ Kirkpatrick, MS Roberts… - International journal of …, 2010 - Elsevier
The objectives of this study were (i) to compare the plasma concentration–time profiles for
first-dose and steady-state piperacillin administered by intermittent or continuous dosing to …

[PDF][PDF] Kirkpatrick

D Kirkpatrick - 2000 - commons.emich.edu
Kirkpatrick, a senior fel low with the American Asso ciation of … Kirkpatrick brings to EMU
an impressive academic and … Having a strong back ground in academics, Kirkpatrick has …

Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients

JA Roberts, CMJ Kirkpatrick… - Journal of Antimicrobial …, 2011 - academic.oup.com
Infections in critically ill patients continue to result in unacceptably high morbidity and mortality.
Although few data exist for correlating antibiotic exposure with outcome, antibiotic dosing …

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

…, P Jarrett, K Klein, SC Wallis, K Patel, CMJ Kirkpatrick… - Critical Care, 2015 - Springer
Introduction The aim of this study was to explore the impact of augmented creatinine clearance
and differing minimum inhibitory concentrations (MIC) on piperacillin pharmacokinetic/…

The therapeutic monitoring of antimicrobial agents

…, ML Barclay, CMJ Kirkpatrick - British Journal of Clinical …, 2001 - Wiley Online Library
Aims To review the basis and optimal use of therapeutic drug monitoring of antimicrobial
agents. Methods Antimicrobial agents for which a reasonable case exists for therapeutic drug …